More Information on 'Revvity Finland'

Revvity Finland provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. With a focus on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection, and diagnosis, informatics, and more, the company revolutionizes healthcare. Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia, and governments, with over $3 billion in revenue and 11,000 employees, and is part of the S&P 500 index with customers in over 190 countries. The company's product and service offerings include research and development solutions, clinical and diagnostics, platforms and automation, and advanced services and licensing.

About Revvity Finland
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.